Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 421 AL 435

PUBMED

Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database.

Kalathur RK, Hernández-Prieto MA, Futschik ME.

BMC Neurol. 2012 Jun 28;12:47. doi: 10.1186/1471-2377-12-47.

0

0

0

PUBMED

Deep brain stimulation in Huntington's disease: A 4-year follow-up case report.

Spielberger S, Hotter A, Wolf E, Eisner W, Müller J, Poewe W, Seppi K.

Mov Disord. 2012 May;27(6):806-7; author reply 807-8. doi: 10.1002/mds.24959. No abstract available.

0

0

0

PUBMED

Benign hereditary chorea 2: pathological findings in an autopsy case.

Yoshida Y, Nunomura J, Shimohata T, Nanjo H, Miyata H.

Neuropathology. 2012 Oct;32(5):557-65. doi: 10.1111/j.1440-1789.2011.01288.x.

0

0

0

PUBMED

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.

Cubo E, González M, del Puerto I, de Yébenes JG, Arconada OF, Gabriel y Galán JM; European Huntington's Disease Initiative Study Group..

Mov Disord. 2012 Mar;27(3):439-42. doi: 10.1002/mds.24062.

0

0

0

PUBMED

The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.

Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB, Ferrante RJ, Hersch S, Kazantsev AG.

Cell Rep. 2012 Dec 27;2(6):1492-7. doi: 10.1016/j.celrep.2012.11.001.

0

0

0

PUBMED

Age, CAG repeat length, and clinical progression in Huntington's disease.

Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA.

Mov Disord. 2012 Feb;27(2):272-6. doi: 10.1002/mds.24024.

0

0

0

PUBMED

Measures of growth in children at risk for Huntington disease.

Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P.

Neurology. 2012 Aug 14;79(7):668-74. doi: 10.1212/WNL.0b013e3182648b65.

0

0

0

PUBMED

High resolution impedance manometric findings in dysphagia of Huntington's disease.

Lee TH, Lee JS, Kim WJ.

World J Gastroenterol. 2012 Apr 14;18(14):1695-9. doi: 10.3748/wjg.v18.i14.1695.

0

0

0

PUBMED

Fifth Annual Huntington Disease Clinical Research Symposium. Organized by the Huntington Study Group.

[No authors listed]

Neurotherapeutics. 2012 Jan;9(1):226-39. doi: 10.1007/s13311-011-0083-8. No abstract available.

0

0

0

PUBMED

BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice.

Reiner A, Wang HB, Del Mar N, Sakata K, Yoo W, Deng YP.

Brain Res. 2012 Sep 14;1473:161-72. doi: 10.1016/j.brainres.2012.07.026.

0

0

0

PUBMED

8-OHdG: its (limited) potential as a biomarker for Huntington's disease.

Killoran A, Biglan KM.

Biomark Med. 2012 Dec;6(6):777-80. doi: 10.2217/bmm.12.84. No abstract available.

0

0

0

PUBMED

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019.

0

0

0

PUBMED

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, Mc

Hum Genet. 2012 Dec;131(12):1833-40. doi: 10.1007/s00439-012-1205-z.

0

0

0

PUBMED

Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington's disease mice.

Li X, Valencia A, McClory H, Sapp E, Kegel KB, Difiglia M.

Biochem Biophys Res Commun. 2012 May 18;421(4):727-30. doi: 10.1016/j.bbrc.2012.04.070.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy